Latest Articles

Subject

Research Article
Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
Huah Shin Ng, Feng Zhu, Elaine Kingwell, et al.

June 14, 2022
Correction & Replacement
Multimodal Investigation of Neuroinflammation in Aviremic Patients With HIV on Antiretroviral Therapy and HIV Elite Controllers
June 10, 2022
Research Article
CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid Cells
Kirsten Guse, Nina Hagemann, Lisa Thiele, et al.

June 08, 2022
Research Article
Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis
Marina Rode von Essen, Rikke Holm Hansen, Camilla Højgaard, et al.

June 07, 2022
Research Article
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis
Marta Pengo, Silvia Miante, Silvia Franciotta, et al.

May 23, 2022
Clinical/Scientific Note
βIV-Spectrin Autoantibodies in 2 Individuals With Neuropathy of Possible Paraneoplastic OriginA Case Series
Christopher M. Bartley, Thomas T. Ngo, Bonny D. Alvarenga, et al.

May 17, 2022
Research Article
Transitioning From S1P Receptor Modulators to B Cell–Depleting Therapies in Multiple SclerosisClinical, Radiographic, and Laboratory Data
William M. Rowles, Wan-Yu Hsu, Kira McPolin, et al.

May 17, 2022
Research Article
Clinicopathologic Profiles of Sporadic Late-Onset Nemaline MyopathyPractical Importance of Anti–α-Actinin Immunostaining
Bing Zhao, Tingjun Dai, Dandan Zhao, et al.

May 17, 2022
Research Article
Innate Immune Cell–Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis
Olavi Misin, Markus Matilainen, Marjo Nylund, et al.

May 17, 2022
Research Articles
Role of Chitinase 3–like 1 as a Biomarker in Multiple SclerosisA Systematic Review and Meta-analysis
Stefano Floro, Tiziana Carandini, Anna Margherita Pietroboni, et al.

May 09, 2022

Pages